Filtered Trial for Telmisartan 40mg Non-responder

Summary

The primary purpose of this study is to: Demonstrate that a fixed-dose combination of telmisartan 40 mg plus amlodipine 5 mg is superior to telmisartan 40 mg alone in patients with essential hypertension and inadequately controlled with telmisartan 40 mg monotherapy.

Timeline

Start

2007-10

Primary completion

2008-07

Completion

—

Drugs

Indications